DSPP and benign prostatic hyperplasia: Future longitudinal prospective cohort studies of BSP and DSPP expression in a large patient population with BPH and pAdC will be required to determine their utility in the diagnosis of prostatic neoplasms, as well as their utility as therapeutic target and outcome determinant in patients with prostatic neoplasms.